The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:The Netherlands Cancer Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9343
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
The Netherlands Cancer Institute (NCI) is a research institute that offers cancer research and treatment services. The institute conducts research in the areas of cell biology, diagnostic oncology, medical oncology, molecular carcinogenesis, biochemistry, biological stress response, gene regulation, immunology, psychosocial research, pharmacology, psychological research and epidemiology, among others. It provides scientific and clinical development and training services. The institute operates various facilities including bioanalytical laboratory of the pharmacy, biostatistics center, carcinogen laboratory, digital microscopy facility, bioimaging facility, biotherapeutics unit, flow cytometry facility, protein facility, and others. NCI is headquartered in Amsterdam, the Netherlands.

The Netherlands Cancer Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Netherlands Cancer Institute, Medical Devices Deals, 2012 to YTD 2018 9
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Kite Pharma Enters into Option Agreement with Netherlands Cancer Institute to License T Cell Receptor Cancer Immunotherapy Product Candidates 11
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 12
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 13
Licensing Agreements 14
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 14
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 15
The Netherlands Cancer Institute – Key Competitors 16
The Netherlands Cancer Institute – Key Employees 17
The Netherlands Cancer Institute – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Jun 12, 2018: Cancer: More targeted use of immunotherapy 19
Aug 22, 2017: Studies highlight ‘potential new targets for immunotherapy’ 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Key Facts 2
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Netherlands Cancer Institute, Deals By Therapy Area, 2012 to YTD 2018 8
The Netherlands Cancer Institute, Medical Devices Deals, 2012 to YTD 2018 9
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Kite Pharma Enters into Option Agreement with Netherlands Cancer Institute to License T Cell Receptor Cancer Immunotherapy Product Candidates 11
Neon Therapeutics Enters into Research Agreement with Netherlands Cancer Institute 12
Elekta Enters Into Agreement With Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital For Cancer Solutions 13
Neon Therapeutics Enters into Licensing Agreement with Netherlands Cancer Institute 14
Forma Therapeutics Enters Into Licensing Agreement With Netherlands Cancer Institute 15
The Netherlands Cancer Institute, Key Competitors 16
The Netherlands Cancer Institute, Key Employees 17
The Netherlands Cancer Institute, Subsidiaries 18

List of Figures
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
The Netherlands Cancer Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
The Netherlands Cancer Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[The Netherlands Cancer Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sirius XM Radio Inc. (SIRI):企業の財務・戦略的SWOT分析
    Sirius XM Radio Inc. (SIRI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Kadant Inc. (KAI):企業の財務・戦略的SWOT分析
    Kadant Inc. (KAI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Red Sky Energy Ltd (ROG):石油・ガス:M&Aディール及び事業提携情報
    Summary Red Sky Energy Ltd (Red Sky Energy) is an oil and gas exploration company that explores, develops, and produces oil and coal steam gas. The company’s gas projects comprise Taroom Trough Project and Clarence Moreton project. Its Clarence Moreton project operates a gas reserve position in Wall …
  • Olin Corporation
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Timberwest Forest Corporation:企業の戦略・SWOT・財務分析
    Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report Summary Timberwest Forest Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Intracom Holdings SA (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings SA (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • CRH public limited company (CRG):企業の財務・戦略的SWOT分析
    CRH public limited company (CRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • CPI Aerostructures, Inc.:企業の戦略・SWOT・財務分析
    CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report Summary CPI Aerostructures, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • VEON Ltd:企業の戦略・SWOT・財務情報
    VEON Ltd - Strategy, SWOT and Corporate Finance Report Summary VEON Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Caterpillar Inc (CAT):企業の財務・戦略的SWOT分析
    Caterpillar Inc (CAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Novozymes AS (NZYM B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novozymes AS (Novozymes) is a biotech company that produces, markets and sells a range of industrial enzymes and microorganisms. The company provides enzymes for detergents, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning …
  • Progenics Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Progenics Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Salt Lake Potash Ltd (SO4):企業の財務・戦略的SWOT分析
    Summary Salt Lake Potash Ltd (Salt Lake Potash), formerly Wildhorse Energy Ltd, is a mining and mineral exploration and development company that develops and evaluates underground coal gasification projects and uranium deposits. The company operates exploration and mining activities with geographic …
  • Little Caesar Enterprises Inc:企業の戦略・SWOT・財務分析
    Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report Summary Little Caesar Enterprises Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Canadian Broadcasting Corp:企業の戦略的SWOT分析
    Canadian Broadcasting Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Bloomberg L.P.:戦略・SWOT・企業財務分析
    Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report Summary Bloomberg L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BB&T Corporation:企業のM&A・事業提携・投資動向
    BB&T Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BB&T Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Acorn Energy, Inc. (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • The GPT Group:企業のM&A・事業提携・投資動向
    The GPT Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The GPT Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆